FilingReader Intelligence

Hualan Biological Engineering unit obtains plasma collection license

May 19, 2025 at 09:52 AM UTCBy FilingReader AI

Hualan Biological Engineering Co., Ltd. (SZSE:002007) announced today that its wholly-owned subsidiary, Hualan Biological Engineering Chongqing Co., Ltd., has received a Plasma Collection License for its Fengdu Plasma Station from the Chongqing Municipal Health Commission, effective May 14, 2025. This license enables the Fengdu Plasma Station to officially commence plasma collection operations, encompassing the collection of ordinary raw material plasma, tetanus immune raw material plasma, rabies immune raw material plasma, and hepatitis B immune raw material plasma within the Fengdu County of Chongqing. The license is valid until May 13, 2027. The company believes that securing this license will significantly enhance its raw material plasma supply and contribute positively to its long-term growth.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:002007Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Hualan Biological Engineering publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →